Skip to content

Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing

Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06291662
Enrollment
12
Registered
2024-03-04
Start date
2021-01-01
Completion date
2025-06-30
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Neoplasm, Pelvic Bone Neoplasm, Sarcoma

Brief summary

Technologies 3D are demonstrating enormous potential for innovation in the field of surgery,introducing the concept of treatment customization (from planning surgery to implant design and manufacturing) on the patient's anatomy, simply by taking advantage of the patient's own common diagnostic images and the flexibility of 3D printing. In fact, this new construction technology allows the construction of the complex anatomical geometries with economy, simplicity and on scales of production unattainable by other traditional technologies. This new construction technology allows, in fact, the construction of complex anatomical geometries with economy, simplicity and on scales of production unattainable by other traditional technologies.

Interventions

DEVICE3D printer applications

Patients will undergo TC/MRI as per routinary care. Custom 3D-devices will be printed on the basis of these images. The device will be used to establish pre-operative surgical options in terms of tissue/bones demolition/reconstruction.

Sponsors

Kathleen McGreevy
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Oncologic patients

Eligibility

Sex/Gender
ALL
Age
7 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Primary tumor of the pelvic bone Primary meta-diaphysial tumor of the long bones; squamous cell carcinoma of the oral cavity in the upper and/or lower jaw. over 10 years of age * Primary sarcoma of bone and soft parts involving the scapula, the pelvis and upper and lower limbs; brain tumor aged 7-18 years * Intracranial oncologic pathology with bone involvement and lesions of the skull theca primary or secondary aged 18-70years * signed informed consent form

Exclusion criteria

* inoperability; * presence of pathological fractures.

Design outcomes

Primary

MeasureTime frameDescription
3D model feasibility for pre-surgical making decisionsthrough study completion, an average of 1 yearNumber of cases in which the time interval between prescription and delivery of the device exceeds 20 days
Surgical timethrough study completion, an average of 1 yearNumber of procedures in which the surgical outcome can be considered optimal (taking planning as a reference) by comparing CT images and evaluating the margins at final histologic analysis.
Device feasibilitythrough study completion, an average of 1 yearProportion of failed surgeries due to a positive or contaminated finding of the margin of bone resection on final histological examination. verified by comparing the expected outcome (i.e., planning output) and the actual outcome (on the postoperative CT scan).

Countries

Italy

Contacts

Primary ContactKathleen McGreevy, PhD
kathleen.mcgreevy@meyer.it055 5662644

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026